Literature DB >> 1936785

Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients.

S B Cogliatti1, U Schmid, U Schumacher, F Eckert, M L Hansmann, J Hedderich, H Takahashi, K Lennert.   

Abstract

Resection specimens from 145 patients with primary B-cell gastric lymphoma at stage IE (n = 88) and at stage IIE (n = 57) were investigated. Histologically, low-grade malignant B-cell lymphomas arising from the mucosa-associated lymphoid tissue, including immunocytoma (n = 71), could be distinguished from high-grade malignant B-cell lymphomas with (n = 25) and without (n = 49) evidence of a low-grade component. The very rare low-grade B-cell lymphomas of centroblastic-centrocytic, centrocytic, and plasmacytic type were not considered. All patients had undergone primary gastric resection, and 65 received additional chemotherapy (n = 33), radiotherapy (n = 22), or both (n = 10). Actuarial overall survival rates calculated by the Kaplan-Meier life-table method were 76% after 5 years and 58% after 10 years. According to the Mantel test and a multivariate analysis using the Cox regression method, patients at stage IE had a significantly better survival probability than those at stage IIE (P less than 0.0001); 5-year survival rates were 87% and 61%, respectively. The survival probability for low-grade malignant lymphomas was significantly better than for tumors with secondary high-grade transformation (P less than 0.05) or for primary high-grade lymphomas (P less than 0.0001), whereas the two high-grade groups were not significantly different. Five-year survival rates were 91% for low-grade, 73% for secondary high-grade, and 56% for primary high-grade malignant lymphomas. Retrospectively, no significantly different survival rates were found between patients who had undergone gastric resection alone and patients who had received additional treatment. However, survival analyses showed that classification and grading according to the histopathological concept of mucosa-associated lymphoid tissue-derived gastric lymphomas into low-grade B-cell lymphomas of mucosa-associated lymphoid tissue type and high-grade B-cell lymphomas with or without evidence of a low-grade component has great prognostic relevance.

Entities:  

Mesh:

Year:  1991        PMID: 1936785     DOI: 10.1016/0016-5085(91)90063-q

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  60 in total

1.  MALT Lymphoma of the Gastric Remnant After Roux-en-Y Gastric Bypass.

Authors:  Ahmed Jawad; Allan H Bar; Demetri Merianos; Jing Zhou
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Regression of atypical lymphoid hyperplasia after eradication of Helicobacter pylori.

Authors:  T Tanahashi; Y Tatsumi; N Sawai; Y Yamaoka; M Nakajima; T Kodama; K Kashima
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 3.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.

Authors:  M-Q Du; J C Atherton
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 4.  Current status of gastric MALT lymphoma.

Authors:  T Wündisch; M Stolte
Journal:  Curr Gastroenterol Rep       Date:  2006-10

5.  MALT lymphoma of the paranasal sinuses and the hard palate: report of two cases and review of the literature.

Authors:  Stefan Tauber; Andreas Nerlich; Stephan Lang
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-01       Impact factor: 2.503

6.  Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.

Authors:  Agustín Avilés; Natividad Neri; M Jesús Nambo; Judith Huerta-Guzman; Sergio Cleto
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

7.  Ileal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with a Large-Cell Component That Regressed Spontaneously.

Authors:  Yohsuke Makino; Hidekazu Suzuki; Toshihiro Nishizawa; Kaori Kameyama; Tadakazu Hisamatsu; Hiroyuki Imaeda; Makio Mukai; Toshifumi Hibi
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

8.  Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features.

Authors:  T Yoshino; K Omonishi; K Kobayashi; T Mannami; H Okada; M Mizuno; I Yamadori; E Kondo; T Akagi
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

9.  Choosing the right MALT.

Authors:  A C Wotherspoon
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

10.  [Gastric MALT-type lymphoma. Pathology, pathogenesis, diagnostics and therapy].

Authors:  M Eck; W Fischbach
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.